REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Takeda Indonesia (Indonesia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: PT Takeda Indonesia Profile Updated: November 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

PT Takeda Indonesia is an enterprise based in Indonesia. Its main office is in South Jakarta. It operates in the Pharmaceutical and Medicine Manufacturing sector. It was incorporated on July 01, 1971. The total number of employees is currently 303 (2011). There was a net sales revenue increase of 1.94% reported in PT Takeda Indonesia’s latest financial highlights for 2023. Its total assets grew by 2.93% over the same period.

Headquarters
Kota Jakarta Selatan Kuningan Timur Setia Budi Dki Jakarta
South Jakarta; Jakarta; Postal Code: 12950

Contact Details: Purchase the PT Takeda Indonesia report to view the information.

Website: http://www.takeda.co.id

Basic Information
Total Employees:
Purchase the PT Takeda Indonesia report to view the information.
Outstanding Shares:
Purchase the PT Takeda Indonesia report to view the information.
Registered Capital:
Purchase the PT Takeda Indonesia report to view the information.
Incorporation Date:
July 01, 1971
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
President Commissioner
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Takeda Indonesia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
1.94%
Total operating revenue
1.94%
Total assets
2.93%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?